This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of Botox. The contract is a firm-fixed-price delivery order with a ceiling value of $13,971.12 and an ultimate completion date of October 17, 2024. The contract does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by various defense and...
This is a $7,693.11 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 200 unit vials of BOTOX, a therapeutic medication, with a period of performance through February 4, 2025. The award is not associated with a set-aside program and is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 200-unit vials of BOTOX, with a ceiling value of $3,492.78 and a completion date of August 6, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the procurement of 4,566,830,898 units of BOTOX 100 unit vials, with a ceiling value of $5,168.16. The contract is a firm-fixed-price, delivery order type and does not have a set-aside designation, indicating it was open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of 200-unit vials of Botox, a specialty medication. The fixed-price contract has a ceiling value of $5,821.30 and a performance period ending on September 18, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) the DLA has with Amerisourcebergen, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 100 unit vials of Botox, a specialty medication, with a ceiling value of $4,296.60 and a completion date of December 24, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 200 unit vials of the drug BOTOX. The award has a ceiling value of $3,492.78 and a completion date of September 6, 2024. The contract is a firm fixed price delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award, valued at $5,128.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of the drug BOTOX, with a completion date of January 29, 2025. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $27,942.24 contract is for the delivery of 200-unit vials of the drug BOTOX, with a period of performance through August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a wide...
This is a federal delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is for the provision of 200-unit vials of the drug BOTOX, with a ceiling value of $1,164.26 and a performance period ending on September 18, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...